期刊文献+

14-3-3β在食管鳞癌组织中的表达及临床意义

The expression of 14-3-3β in esophageal squamous cell carcinoma tissue and the clinical significance
原文传递
导出
摘要 目的研究14-3-3β在人体食管鳞癌的表达,探讨其表达与临床病理及预后的相关性。方法免疫组织化学法检测组织芯片中78例食管鳞癌和其配对的癌旁正常组织的表达。结果14-3-3β在食管鳞癌组织细胞核中中度阳性及强阳性占62.8%(49/78);在癌旁正常组织中中度阳性及强阳性占17.9%(14/78),两者比较差异有统计学意义(P〈0.01);14-3-3β蛋白在食管鳞癌组织细胞质中中度阳性及强阳性占69.2%(54/78);在癌旁正常组织中中度阳性及强阳性占29.5%(23/78),两者比较差异有统计学意义(P〈0.01)。14-3-3β表达与食管鳞癌的分化程度有关,随着分化程度的降低,14-3-3β在细胞质和细胞核中均高表达(P〈0.01),与性别、年龄、TNM分期、肿瘤的大小和生存率无相关性(P〉0.05)。结论14-3-3β在食管鳞癌中表达上调,该蛋白高表达于细胞核和细胞质,并与肿瘤分化程度呈正相关。 Objective To investigate the expression of 14-3-3 β in esophageal squamous cell carcinoma (ESSC) tissue, and to explore the relationship between 14-3-3 β and clinieopathological factors, prognosis. Methods The 14-3-3β expressed in tumors and adjacent normal epithelia from 78 esophageal squamous cell carcinoma patients was detected by immunohistochemical staining. Results The mild and strong expression in the nucleus of esophageal squamous cell careinoma and adjacent tissues was 62.8% (49/78) and 17.9% (14/78),there was significant difference (P 〈 0.01 ). The mild and strong expression in the cytoplasm of esophageal squamous cell carcinoma and adjacent tissues was 69.2% (54/78) and 29.5% (23/78), there was significant difference (P 〈 0.01 ). The 14-3-3β was associated with the differentiation degree of esophageal squamous cell carcinoma(P 〈 0.01 ). It had nothing to do with sex, age, TNM stage, size and survival rate (P 〉 0.05). Conclusions The expression of 14-3-3β is significantly up-regulated in esophageal squamous cell carcinoma patients. The expression of 14-3-3β in the nucleus and cytoplasm is higher and has positively associated with tumor differentiation degree.
出处 《中国医师进修杂志》 2014年第25期1-5,共5页 Chinese Journal of Postgraduates of Medicine
基金 国家自然科学基金(81001101)
关键词 食管肿瘤 14-3-3β蛋白类 淋巴结 Esophageal neoplasms 14-3-3 β proteins Lymph node
  • 相关文献

参考文献25

  • 1Parkin DM, Bray F, Ferlay J, et al. Global cancer statistics, 2002 [J]. CA Cancer J Clin, 2005,55(2) :74-108.
  • 2Aitken A.14-3-3 proteins: a historic overview [J]. Semin Cancer Biol, 2006,16(3) : 162-172.
  • 3Shikano S, Coblitz B, Wu M, et al. 14-3-3 proteins: regulation of endoplasmic reticulum localization and surface expression of membrane proteins[J]. Trends Cell Biol, 2006,16(7):370-375.
  • 4Pozuelo Rubio M, Geraghty KM, Wong BH, et al.14-3-3-affinity purification of over 200 human phosphoproteins reveals new links to regulation of cellular metabolism, proliferation and trafficking[J]. Biochem J, 2004,379 Pt 2: 395-408.
  • 5Satoh J, Nanri Y, Yamamnra T. Rapid identification of 14-3-3- binding proteins by protein microarray analysis [J]. J Neurosci Methods, 2006,152(1/2) : 278-288.
  • 6Hermeking H.14-3-3 proteins and cancer biology[J]. Semin Cancer Biol,2006,16(3 ) : 161.
  • 7Zannis-Hadjopoulos M, Yahyaoui W, Callejo M.14-3-3 cruciform- binding proteins as regulators of eukaryotic DNA replication [J]. Trends Biochem Sci ,2008,33( 1 ) :44-50.
  • 8Simooka H, Oyama T, Sano T, et al. Immunohistoehemical analysis of 14-3-3 sigma and related proteins in hyperplastic and neoplastic breast lesions, with particula reference to early carcinogenesis [ J ]. Pathol Int, 2004,54 ( 8 ) : 595-602.
  • 9Osada H, Tatematsu Y, Yatabe Y, et al. Frequent and histological type-specific inactivation of 14-3-3sigma in human lung cancers[ J ]. Oncogene,2002,21 ( 15 ) :2418-2424.
  • 10Cheng L, Pan CX, Zhang JT,et al. Loss of 14-3-3sigma in prostate cancer and its precursors [ J ]. Clin Cancer Res, 2004,10 (9) : 3064- 3068.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部